https:\/\/www.thebusinessresearchcompany.com\/sample.aspx?id=774&type=smp<\/a><\/p>\n North America is the leading region for both biologic and other pharma sales but the story is different in second and third place. Asia Pacific has overtaken Western Europe in small-molecule drug sales but in biologics, Western Europe is still well ahead of Asia Pacific. The high cost of biologics, making them more affordable in affluent Western Europe, the greater prevalence there of the age-related diseases that many current biologics are designed to treat, and the more rapid growth of the biosimilars market in Asia Pacific account for this difference.<\/p>\n The USA’s biologics market is by far the world’s largest, worth seven times that of the second largest, Japan. Growth, however is widespread, with the BRICs (Brazil, Russia, India and China) in the lead. For instance, growth in India’s tiny market has surged recently, from the 12.4% CAGR it was achieving up to 2017, to 21%. Growth has also accelerated in the European markets – the UK, France, Spain, German and Italy are all now seeing double-digit growth, as is the otherwise often somnolent market of Japan. Growth in the US market, though a little slower in percentages, is of course worth most in dollars.<\/p>\n Where To Learn More<\/strong><\/p>\n Read the Biologics Global Market Report 2018<\/a> from The Business Research Company for information on the following:<\/p>\n Markets Covered: <\/strong>Biologics,healthcare services, pharmaceutical drugs, medical equipment.<\/p>\n Biologics Market Companies Covered:<\/strong> Johnson & Johnson, F. Hoffmann-La Roche Ltd., Bristol-Myers Squibb Company, GlaxoSmithKline Plc., AbbVie, Amgen, Sanofi S.A., Eli Lilly and Company, Merck & Co., Pfizer<\/p>\n Regions:<\/strong> North America, Asia Pacific, Western Europe, South America, Eastern Europe, Middle East, Africa.<\/p>\n Countries:<\/strong> USA, China, UK, Japan, France, Germany, Australia, India, Spain, Russia, Italy, Brazil<\/p>\n Time Series:<\/strong> Five years historic (2013-17) and forecast (2017-21).<\/p>\n Data Segmentations:<\/strong> Biologics market historic and forecast size and growth rates for the world, 7 regions and 12 countries, therapeutic proteins, monoclonal antibodies (MAbS), and vaccines segments historic and forecast size, segment share, and growth rates for the world, 7 regions and 12 countries, global competitor sales and market shares. <\/p>\n Healthcare market segment shares for the world, 7 regions and 12 countries.<\/p>\n Other Data: <\/strong>Per capita average biologics expenditure, global and by country, biologics market size as a percentage of GDP across countries, biologics and biosimilars drugs sales proportion, number of general practitioners for 12 countries.<\/p>\n Other Information: <\/strong>Drivers and restraints of the global biologics market, PESTEL analysis, company profiles including products, strategy and financial performance for 10 biologics companies, biologics market trends and strategies, biologics market key mergers and acquisitions<\/p>\n Sourcing and Referencing:<\/strong> Data and analysis throughout the report are sourced using end notes. Sources include primary as well as extensive secondary research.<\/p>\n Number of Figures in the report: 84<\/p>\n Number of Tables in the report: 82<\/p>\n Interested to know more? Here is a list of reports similar to “Biologics Global Market Report 2018”:<\/strong><\/p>\n Pharmaceutical Drugs Global Market Report 2018<\/a><\/p>\n Bio-Pharmaceutical Logistics Global Market Report 2018<\/a><\/p>\n Table of Contents<\/strong><\/p>\n Executive Summary……………………………………………………………………………………………………………………………… 17<\/p>\n Biologics Market Characteristics…………………………………………………………………………………………………………….. 18<\/p>\n Market Overview…………………………………………………………………………………………………………………………….. 18<\/p>\n Market Segmentation……………………………………………………………………………………………………………………….. 20<\/p>\n Market Value Chain………………………………………………………………………………………………………………………….. 22<\/p>\n Biologics Market Size And Growth………………………………………………………………………………………………………….. 24<\/p>\n Biologics Historic Market Growth………………………………………………………………………………………………………… 24<\/p>\n Drivers Of The Market………………………………………………………………………………………………………………………. 25<\/p>\n Restraints On The Market………………………………………………………………………………………………………………….. 26<\/p>\n Biologics Market Forecast Growth……………………………………………………………………………………………………….. 27<\/p>\n Drivers Of The Market………………………………………………………………………………………………………………………. 28<\/p>\n Increase In Healthcare Access………………………………………………………………………………………………………….. 28<\/p>\n Restraints On The Market………………………………………………………………………………………………………………….. 29<\/p>\n PESTLE Analysis…………………………………………………………………………………………………………………………………… 30<\/p>\n Political………………………………………………………………………………………………………………………………………. 31<\/p>\n Economic……………………………………………………………………………………………………………………………………. 31<\/p>\n Social…………………………………………………………………………………………………………………………………………. 31<\/p>\n Technological………………………………………………………………………………………………………………………………. 32<\/p>\n Legal………………………………………………………………………………………………………………………………………….. 32<\/p>\n Environmental……………………………………………………………………………………………………………………………… 32<\/p>\n Biologics Market Segmentation……………………………………………………………………………………………………………… 33<\/p>\n Global Biologics Market, 2017, Split By Segments, $ Billion……………………………………………………………………….. 33<\/p>\n Monoclonal Antibodies (mAbs)……………………………………………………………………………………………………….. 34<\/p>\n Therapeutic Proteins…………………………………………………………………………………………………………………….. 34<\/p>\n Vaccines……………………………………………………………………………………………………………………………………… 34<\/p>\n Global Biologics Market, Historic and Forecast Growth Rates, Split By Segments, 2013-2021…………………………… 35<\/p>\n Global Biologics Market Trends And Strategies………………………………………………………………………………………….. 36<\/p>\n Demand For Biologics In The Treatment Of Complex Diseases…………………………………………………………………… 36<\/p>\n Development And Increasing Demand For Next Generation Biologics…………………………………………………………. 36<\/p>\n Revised FDA Regulations To Facilitate Biologics Drug Development……………………………………………………………. 37<\/p>\n Higher Profit Margins For Biologics……………………………………………………………………………………………………… 37<\/p>\n Higher Investments………………………………………………………………………………………………………………………….. 37<\/p>\n Global Biologics Market Compared With Similar Markets, 2017…………………………………………………………………….. 38<\/p>\n Healthcare Market Segmentation, By Region, 2017……………………………………………………………………………… 38<\/p>\n Healthcare Market Segmentation, By Country, 2017……………………………………………………………………………. 39<\/p>\n Global Biologics Market Segment Details………………………………………………………………………………………………. 41<\/p>\n Monoclonal Antibodies (mAbs)…………………………………………………………………………………………………………… 41<\/p>\n Monoclonal Antibodies Market Characteristics…………………………………………………………………………………… 41<\/p>\n Global Monoclonal Antibodies Market, 2017, By Source……………………………………………………………………….. 41<\/p>\n Global Monoclonal Antibodies Market, 2017, By Therapeutic Area………………………………………………………….. 43<\/p>\n Monoclonal Antibodies Market Trends And Strategies………………………………………………………………………….. 45<\/p>\n Therapeutic Proteins………………………………………………………………………………………………………………………… 46<\/p>\n Therapeutic Proteins Market Characteristics………………………………………………………………………………………. 46<\/p>\n Global Therapeutic Proteins Market, 2017, By Type……………………………………………………………………………… 46<\/p>\n Global Therapeutic Proteins Market, 2017, By Therapeutic Area…………………………………………………………….. 47<\/p>\n Therapeutic Proteins Market Trends And Strategies…………………………………………………………………………….. 49<\/p>\n Vaccines………………………………………………………………………………………………………………………………………… 50<\/p>\n Vaccines Market Characteristics………………………………………………………………………………………………………. 50<\/p>\n Global Vaccines Market, 2017, By End User………………………………………………………………………………………… 50<\/p>\n Global Vaccines Market, 2017, By Therapeutic Area…………………………………………………………………………….. 51<\/p>\n Vaccines Market Trends And Strategies…………………………………………………………………………………………….. 53<\/p>\n Biologics Market Geography Regional and Country Analysis…………………………………………………………………………. 54<\/p>\n Biologics Market, 2017, By Region……………………………………………………………………………………………………….. 54<\/p>\n Biologics Market, Historic And Forecast Growth Rates, Split By Region, 2013-2021………………………………………… 56<\/p>\n Biologics Market, Split By Country, 2017…………………………………………………………………………………………….58<\/p>\n Biologics Market, Historic And Forecast Growth Rates, Split By Country, 2013-2021………………………………………..60<\/p>\n Global Biologics Market Comparison With Macro Economic Factors………………………………………………………………. 62<\/p>\n Biologics Market Size, Percentage Of GDP, Global…………………………………………………………………………………… 62<\/p>\n Per Capita Average Biologics Expenditure, Global…………………………………………………………………………………… 63<\/p>\n Biologics Market Comparison With Macro Economic Factors Across Countries…………………………………………………. 64<\/p>\n Biologics Market Size, Percentage of GDP, By Country……………………………………………………………………………… 64<\/p>\n Per Capita Average Biologics Expenditure, By Country……………………………………………………………………………… 65<\/p>\n Biologics Market Comparison With Industry Metrics…………………………………………………………………………………… 66<\/p>\n Biologics & Biosimilars Sales Proportion By Country (Value), 2017, By Country……………………………………………… 66<\/p>\n Global Biologics Under Development, 2017…………………………………………………………………………………………… 68<\/p>\n New Biologics Approvals, 2017…………………………………………………………………………………………………………… 69<\/p>\n Number Of General Practitioners 2016, By Country………………………………………………………………………………… 70<\/p>\n Average Revenue Per General Practitioner 2016, By Country…………………………………………………………………….. 71<\/p>\n Biologics Market Regional And Country Analysis………………………………………………………………………………………… 72<\/p>\n Asia-Pacific Biologics Market…………………………………………………………………………………………………………………. 72<\/p>\n Asia-Pacific Biologics Market Overview…………………………………………………………………………………………………. 72<\/p>\n Region Information……………………………………………………………………………………………………………………….. 72<\/p>\n General Information……………………………………………………………………………………………………………………… 72<\/p>\n Government Initiatives………………………………………………………………………………………………………………….. 72<\/p>\n Regulations…………………………………………………………………………………………………………………………………. 73<\/p>\n Regulatory Bodies…………………………………………………………………………………………………………………………. 73<\/p>\n Investments………………………………………………………………………………………………………………………………… 73<\/p>\n Associations………………………………………………………………………………………………………………………………… 74<\/p>\n Competitive Landscape………………………………………………………………………………………………………………….. 74<\/p>\n Asia Pacific Biologics Market………………………………………………………………………………………………………………. 74<\/p>\n Asia-Pacific Biologics Historic Market, 2013-2017……………………………………………………………………………………. 74<\/p>\n Asia-Pacific Biologics Forecast Market, 2017-2021………………………………………………………………………………….. 75<\/p>\n Asia-Pacific Biologics Market, 2017, By Segment…………………………………………………………………………………….. 76<\/p>\n Asia-Pacific Biologics Market: Country Analysis………………………………………………………………………………………. 78<\/p>\n China Biologics Market Overview………………………………………………………………………………………………………… 78<\/p>\n Country Information……………………………………………………………………………………………………………………… 78<\/p>\n General Information……………………………………………………………………………………………………………………… 78<\/p>\n Government Initiatives………………………………………………………………………………………………………………….. 78<\/p>\n Regulations…………………………………………………………………………………………………………………………………. 78<\/p>\n Regulatory Bodies…………………………………………………………………………………………………………………………. 78<\/p>\n Investments………………………………………………………………………………………………………………………………… 78<\/p>\n Associations………………………………………………………………………………………………………………………………… 79<\/p>\n Competitive Landscape………………………………………………………………………………………………………………….. 79<\/p>\n China Biologics Market……………………………………………………………………………………………………………………… 79<\/p>\n China Biologics Historic Market, 2013-2017…………………………………………………………………………………………… 80<\/p>\n China Biologics Forecast Market, 2017-2021………………………………………………………………………………………….. 81<\/p>\n China Biologics Market, 2017, By Segment……………………………………………………………………………………………. 82<\/p>\n India Biologics Market Overview…………………………………………………………………………………………………………. 83<\/p>\n Country Information……………………………………………………………………………………………………………………… 83<\/p>\n General Information……………………………………………………………………………………………………………………… 83<\/p>\n Government Initiatives………………………………………………………………………………………………………………….. 83<\/p>\n Regulations…………………………………………………………………………………………………………………………………. 83<\/p>\n Regulatory Bodies…………………………………………………………………………………………………………………………. 84<\/p>\n Investments………………………………………………………………………………………………………………………………… 84<\/p>\n Associations………………………………………………………………………………………………………………………………… 84<\/p>\n Competitive Landscape………………………………………………………………………………………………………………….. 84<\/p>\n India Biologics Market………………………………………………………………………………………………………………………. 85<\/p>\n India Biologics Historic Market, 2013-2017……………………………………………………………………………………………. 85<\/p>\n India Biologics Forecast Market, 2017-2021…………………………………………………………………………………………… 86<\/p>\n India Biologics Market, 2017, By Segment…………………………………………………………………………………………….. 87<\/p>\n Japan Biologics Market Overview………………………………………………………………………………………………………… 88<\/p>\n Country Information……………………………………………………………………………………………………………………… 88<\/p>\n General Information……………………………………………………………………………………………………………………… 88<\/p>\n Government Initiatives………………………………………………………………………………………………………………….. 88<\/p>\n Regulations…………………………………………………………………………………………………………………………………. 88<\/p>\n Regulatory Bodies…………………………………………………………………………………………………………………………. 88<\/p>\n Investments………………………………………………………………………………………………………………………………… 88<\/p>\n Associations………………………………………………………………………………………………………………………………… 89<\/p>\n Competitive Landscape………………………………………………………………………………………………………………….. 89<\/p>\n Japan Biologics Market……………………………………………………………………………………………………………………… 89<\/p>\n Japan Biologics Historic Market, 2013-2017…………………………………………………………………………………………… 89<\/p>\n Japan Biologics Forecast Market, 2017-2021………………………………………………………………………………………….. 90<\/p>\n Japan Biologics Market, 2017, By Segment……………………………………………………………………………………………. 91<\/p>\n Australia Biologics Market Overview……………………………………………………………………………………………………. 93<\/p>\n Country Information……………………………………………………………………………………………………………………… 93<\/p>\n General Information……………………………………………………………………………………………………………………… 93<\/p>\n Government Initiatives………………………………………………………………………………………………………………….. 93<\/p>\n Regulations…………………………………………………………………………………………………………………………………. 93<\/p>\n Australia Biologics Market…………………………………………………………………………………………………………………. 93<\/p>\n Australia Biologics Historic Market, 2013-2017………………………………………………………………………………………. 94<\/p>\n Australia Biologics Forecast Market, 2017-2021……………………………………………………………………………………… 95<\/p>\n Australia Biologics Market, 2017, By Segment………………………………………………………………………………………… 96<\/p>\n Western Europe Biologics Market…………………………………………………………………………………………………………… 97<\/p>\n Western Europe Biologics Market Overview………………………………………………………………………………………….. 97<\/p>\n Region Information……………………………………………………………………………………………………………………….. 97<\/p>\n General Information……………………………………………………………………………………………………………………… 97<\/p>\n Government Initiatives………………………………………………………………………………………………………………….. 97<\/p>\n Regulations…………………………………………………………………………………………………………………………………. 97<\/p>\n Regulatory Bodies…………………………………………………………………………………………………………………………. 98<\/p>\n Investments………………………………………………………………………………………………………………………………… 98<\/p>\n Associations………………………………………………………………………………………………………………………………… 99<\/p>\n Competitive Landscape………………………………………………………………………………………………………………….. 99<\/p>\n Western Europe Biologics Market……………………………………………………………………………………………………… 100<\/p>\n Western Europe Biologics Historic Market, 2013-2017…………………………………………………………………………… 100<\/p>\n Western Europe Biologics Forecast Market, 2017-2021………………………………………………………………………….. 101<\/p>\n Western Europe Biologics Market, 2017, By Segment…………………………………………………………………………….. 103<\/p>\n Western Europe Biologics Market: Country Analysis………………………………………………………………………………. 104<\/p>\n UK Biologics Market Overview………………………………………………………………………………………………………….. 104<\/p>\n Country Information……………………………………………………………………………………………………………………. 104<\/p>\n General Information……………………………………………………………………………………………………………………. 104<\/p>\n Government Initiatives…………………………………………………………………………………………………………………. 104<\/p>\n Regulations……………………………………………………………………………………………………………………………….. 104<\/p>\n Regulatory Bodies……………………………………………………………………………………………………………………….. 104<\/p>\n Investments……………………………………………………………………………………………………………………………….. 104<\/p>\n Associations………………………………………………………………………………………………………………………………. 105<\/p>\n Competitive Landscape………………………………………………………………………………………………………………… 105<\/p>\n UK Biologics Market……………………………………………………………………………………………………………………….. 106<\/p>\n UK Biologics Historic Market, 2013-2017…………………………………………………………………………………………….. 106<\/p>\n UK Biologics Forecast Market, 2017-2021……………………………………………………………………………………………. 107<\/p>\n UK Biologics Market, 2017, By Segment………………………………………………………………………………………………. 108<\/p>\n Germany Biologics Market Overview………………………………………………………………………………………………….. 109<\/p>\n Country Information……………………………………………………………………………………………………………………. 109<\/p>\n General Information……………………………………………………………………………………………………………………. 109<\/p>\n Government Initiatives…………………………………………………………………………………………………………………. 109<\/p>\n Regulations……………………………………………………………………………………………………………………………….. 109<\/p>\n Regulatory Bodies……………………………………………………………………………………………………………………….. 109<\/p>\n Investments……………………………………………………………………………………………………………………………….. 109<\/p>\n Associations………………………………………………………………………………………………………………………………. 110<\/p>\n Competitive Landscape………………………………………………………………………………………………………………… 110<\/p>\n Germany Biologics Market……………………………………………………………………………………………………………….. 111<\/p>\n Germany Biologics Historic Market, 2013-2017…………………………………………………………………………………….. 111<\/p>\n Germany Biologics Forecast Market, 2017-2021……………………………………………………………………………………. 112<\/p>\n Germany Biologics Market, 2017, By Segment……………………………………………………………………………………… 113<\/p>\n France Biologics Market Overview……………………………………………………………………………………………………… 114<\/p>\n Country Information……………………………………………………………………………………………………………………. 114<\/p>\n General Information……………………………………………………………………………………………………………………. 114<\/p>\n Government Initiatives…………………………………………………………………………………………………………………. 114<\/p>\n Regulations……………………………………………………………………………………………………………………………….. 114<\/p>\n Regulatory Bodies……………………………………………………………………………………………………………………….. 114<\/p>\n Investments……………………………………………………………………………………………………………………………….. 114<\/p>\n Associations………………………………………………………………………………………………………………………………. 115<\/p>\n Competitive Landscape………………………………………………………………………………………………………………… 115<\/p>\n France Biologics Market…………………………………………………………………………………………………………………… 116<\/p>\n France Biologics Historic Market, 2013-2017………………………………………………………………………………………… 116<\/p>\n France Biologics Forecast Market, 2017-2021………………………………………………………………………………………. 117<\/p>\n France Biologics Market, 2017, By Segment…………………………………………………………………………………………. 118<\/p>\n Italy Biologics Market Overview………………………………………………………………………………………………………… 119<\/p>\n Country Information……………………………………………………………………………………………………………………. 119<\/p>\n General Information……………………………………………………………………………………………………………………. 119<\/p>\n Regulations……………………………………………………………………………………………………………………………….. 119<\/p>\n Regulatory Bodies……………………………………………………………………………………………………………………….. 119<\/p>\n Investments……………………………………………………………………………………………………………………………….. 119<\/p>\n Competitive Landscape………………………………………………………………………………………………………………… 119<\/p>\n Italy Biologics Market……………………………………………………………………………………………………………………… 121<\/p>\n Italy Biologics Historic Market, 2013-2017…………………………………………………………………………………………… 121<\/p>\n Italy Biologics Forecast Market, 2017-2021………………………………………………………………………………………….. 122<\/p>\n Italy Biologics Market, 2017, By Segment…………………………………………………………………………………………….. 123<\/p>\n Spain Biologics Market Overview……………………………………………………………………………………………………….. 124<\/p>\n Country Information……………………………………………………………………………………………………………………. 124<\/p>\n General Information……………………………………………………………………………………………………………………. 124<\/p>\n Government Initiatives…………………………………………………………………………………………………………………. 124<\/p>\n Regulations……………………………………………………………………………………………………………………………….. 124<\/p>\n Regulatory Bodies……………………………………………………………………………………………………………………….. 124<\/p>\n Associations………………………………………………………………………………………………………………………………. 124<\/p>\n Competitive Landscape………………………………………………………………………………………………………………… 124<\/p>\n Spain Biologics Market…………………………………………………………………………………………………………………….. 125<\/p>\n Spain Biologics Historic Market, 2013-2017…………………………………………………………………………………………. 125<\/p>\n Spain Biologics Forecast Market, 2017-2021………………………………………………………………………………………… 126<\/p>\n Spain Biologics Market, 2017, By Segment…………………………………………………………………………………………… 127<\/p>\n Eastern Europe Biologics Market…………………………………………………………………………………………………………… 128<\/p>\n Eastern Europe Biologics Market Overview………………………………………………………………………………………….. 128<\/p>\n Region Information……………………………………………………………………………………………………………………… 128<\/p>\n General Information……………………………………………………………………………………………………………………. 128<\/p>\n Government Initiatives…………………………………………………………………………………………………………………. 128<\/p>\n Regulations……………………………………………………………………………………………………………………………….. 128<\/p>\n Regulatory Bodies……………………………………………………………………………………………………………………….. 128<\/p>\n Investments……………………………………………………………………………………………………………………………….. 128<\/p>\n Associations………………………………………………………………………………………………………………………………. 128<\/p>\n Competitive Landscape………………………………………………………………………………………………………………… 128<\/p>\n Eastern Europe Biologics Market……………………………………………………………………………………………………….. 129<\/p>\n Eastern Europe Biologics Historic Market, 2013-2017…………………………………………………………………………….. 129<\/p>\n Eastern Europe Biologics Forecast Market, 2017-2021……………………………………………………………………………. 130<\/p>\n Eastern Europe Biologics Market, 2017, By Segment……………………………………………………………………………… 131<\/p>\n Russia Biologics Market Overview……………………………………………………………………………………………………… 132<\/p>\n Country Information……………………………………………………………………………………………………………………. 132<\/p>\n General Information……………………………………………………………………………………………………………………. 132<\/p>\n Government Initiatives…………………………………………………………………………………………………………………. 132<\/p>\n Regulations……………………………………………………………………………………………………………………………….. 132<\/p>\n Regulatory Bodies……………………………………………………………………………………………………………………….. 132<\/p>\n Investments……………………………………………………………………………………………………………………………….. 132<\/p>\n Associations………………………………………………………………………………………………………………………………. 132<\/p>\n Competitive Landscape………………………………………………………………………………………………………………… 132<\/p>\n Russia Biologics Market…………………………………………………………………………………………………………………… 132<\/p>\n Russia Biologics Historic Market, 2013-2017………………………………………………………………………………………… 133<\/p>\n Russia Biologics Forecast Market, 2017-2021……………………………………………………………………………………….. 134<\/p>\n Russia Biologics Market, 2017, By Segment………………………………………………………………………………………….. 135<\/p>\n North America Biologics Market……………………………………………………………………………………………………………. 136<\/p>\n North America Biologics Market Overview…………………………………………………………………………………………… 136<\/p>\n Region Information……………………………………………………………………………………………………………………… 136<\/p>\n General Information……………………………………………………………………………………………………………………. 136<\/p>\n Regulations……………………………………………………………………………………………………………………………….. 136<\/p>\n Regulatory Bodies……………………………………………………………………………………………………………………….. 136<\/p>\n Investments……………………………………………………………………………………………………………………………….. 137<\/p>\n Competitive Landscape………………………………………………………………………………………………………………… 137<\/p>\n North America Biologics Market………………………………………………………………………………………………………… 137<\/p>\n North America Biologics Historic Market, 2013-2017……………………………………………………………………………… 137<\/p>\n North America Biologics Forecast Market, 2017-2021……………………………………………………………………………. 138<\/p>\n North America Biologics Market, 2017, By Segment………………………………………………………………………………. 140<\/p>\n North America Biologics Market: Country Analysis………………………………………………………………………………… 141<\/p>\n USA Biologics Market Overview…………………………………………………………………………………………………………. 141<\/p>\n Country Information……………………………………………………………………………………………………………………. 141<\/p>\n General Information……………………………………………………………………………………………………………………. 141<\/p>\n Regulations……………………………………………………………………………………………………………………………….. 141<\/p>\n Regulatory Bodies……………………………………………………………………………………………………………………….. 141<\/p>\n Investments……………………………………………………………………………………………………………………………….. 141<\/p>\n Competitive Landscape………………………………………………………………………………………………………………… 141<\/p>\n USA Biologics Market………………………………………………………………………………………………………………………. 141<\/p>\n USA Biologics Historic Market, 2013-2017…………………………………………………………………………………………… 142<\/p>\n USA Biologics Forecast Market, 2017-2021………………………………………………………………………………………….. 144<\/p>\n USA Biologics Market, 2017, By Segment…………………………………………………………………………………………….. 145<\/p>\n South America Biologics Market……………………………………………………………………………………………………………. 146<\/p>\n South America Biologics Market Overview…………………………………………………………………………………………… 146<\/p>\n Region Information……………………………………………………………………………………………………………………… 146<\/p>\n General Information……………………………………………………………………………………………………………………. 146<\/p>\n Government Initiatives…………………………………………………………………………………………………………………. 146<\/p>\n Regulations……………………………………………………………………………………………………………………………….. 146<\/p>\n Regulatory Bodies……………………………………………………………………………………………………………………….. 146<\/p>\n Associations………………………………………………………………………………………………………………………………. 146<\/p>\n Competitive Landscape………………………………………………………………………………………………………………… 146<\/p>\n South America Biologics Market………………………………………………………………………………………………………… 147<\/p>\n South America Biologics Historic Market, 2013-2017……………………………………………………………………………… 147<\/p>\n South America Biologics Forecast Market, 2017-2021……………………………………………………………………………. 148<\/p>\n South America Biologics Market, 2017, By Segment………………………………………………………………………………. 149<\/p>\n South America Biologics Market: Country Analysis………………………………………………………………………………… 151<\/p>\n Brazil Biologics Market Overview……………………………………………………………………………………………………….. 151<\/p>\n Country Information……………………………………………………………………………………………………………………. 151<\/p>\n General Information……………………………………………………………………………………………………………………. 151<\/p>\n Government Initiatives…………………………………………………………………………………………………………………. 151<\/p>\n Regulations……………………………………………………………………………………………………………………………….. 151<\/p>\n Regulatory Bodies……………………………………………………………………………………………………………………….. 151<\/p>\n Associations………………………………………………………………………………………………………………………………. 151<\/p>\n Competitive Landscape………………………………………………………………………………………………………………… 151<\/p>\n Brazil Biologics Market……………………………………………………………………………………………………………………. 152<\/p>\n Brazil Biologics Historic Market, 2013-2017…………………………………………………………………………………………. 152<\/p>\n Brazil Biologics Forecast Market, 2017-2021………………………………………………………………………………………… 153<\/p>\n Brazil Biologics Market, 2017, By Segment…………………………………………………………………………………………… 154<\/p>\n Middle East Biologics Market……………………………………………………………………………………………………………….. 155<\/p>\n Middle East Biologics Market Overview………………………………………………………………………………………………. 155<\/p>\n Region Information……………………………………………………………………………………………………………………… 155<\/p>\n General Information……………………………………………………………………………………………………………………. 155<\/p>\n Regulations……………………………………………………………………………………………………………………………….. 155<\/p>\n Regulatory Bodies……………………………………………………………………………………………………………………….. 155<\/p>\n Investments……………………………………………………………………………………………………………………………….. 155<\/p>\n Competitive Landscape………………………………………………………………………………………………………………… 155<\/p>\n Middle East Biologics Market……………………………………………………………………………………………………………. 156<\/p>\n Middle East Biologics Historic Market, 2013-2017…………………………………………………………………………………. 156<\/p>\n Middle East Biologics Forecast Market, 2017-2021………………………………………………………………………………… 157<\/p>\n Middle East Biologics Market, 2017, By Segment………………………………………………………………………………….. 159<\/p>\n Africa Biologics Market……………………………………………………………………………………………………………………….. 160<\/p>\n Africa Biologics Market Overview………………………………………………………………………………………………………. 160<\/p>\n Region Information……………………………………………………………………………………………………………………… 160<\/p>\n General Information……………………………………………………………………………………………………………………. 160<\/p>\n Regulations……………………………………………………………………………………………………………………………….. 160<\/p>\n Regulatory Bodies……………………………………………………………………………………………………………………….. 160<\/p>\n Investments……………………………………………………………………………………………………………………………….. 161<\/p>\n Associations………………………………………………………………………………………………………………………………. 161<\/p>\n Competitive Landscape………………………………………………………………………………………………………………… 161<\/p>\n Afri When GlaxoSmithKline acquired Swiss company Okairos AG for 250 million euros ($325 million), GSK’s objective was to enable it to develop vaccines in-house; similarly, when CSL acquired the influenza vaccine business of Novartis, a much bigger company and when, in … Continue reading ![\"\"](\"http:\/\/www.abnewswire.com\/uploads\/538e16c29410058db255722b363aa70a.JPG\")
<\/p>\n<\/p>\n","protected":false},"excerpt":{"rendered":"